生物股份跌7.69%，沪股通龙虎榜上净卖出7168.77万元

Core Viewpoint - The stock of BioShares (600201) experienced a significant decline of 7.69% in a single trading day, with a turnover rate of 10.29% and a total transaction value of 1.799 billion yuan, indicating heightened market activity and investor concern [2]. Group 1: Stock Performance - The stock's price drop was attributed to a deviation of -8.23% from its daily limit, leading to its listing on the exchange's watchlist [2]. - The net selling by the Shanghai-Hong Kong Stock Connect amounted to 71.6877 million yuan, marking it as the largest selling entity for the day [2]. - The stock saw a net inflow of 46.8376 million yuan from major funds, with large orders contributing 35.8611 million yuan and big orders adding 10.9764 million yuan [2]. Group 2: Trading Data - The top five trading departments accounted for a total transaction value of 359 million yuan, with buying totaling 148 million yuan and selling reaching 211 million yuan, resulting in a net selling of 63.219 million yuan [2]. - The largest buying department was Guotai Junan Securities Headquarters, with a purchase amount of 41.4571 million yuan [3]. - The largest selling department was the Shanghai-Hong Kong Stock Connect, with a selling amount of 71.6877 million yuan [3]. Group 3: Financial Performance - For the first three quarters, the company reported a revenue of 1.042 billion yuan, reflecting a year-on-year growth of 7.38% [3]. - The net profit for the same period was 161 million yuan, showing a year-on-year decline of 4.85% [3]. Group 4: Margin Trading Data - As of December 23, the margin trading balance for the stock was 1.643 billion yuan, with a financing balance of 1.637 billion yuan and a securities lending balance of 6.0756 million yuan [2]. - Over the past five days, the financing balance increased by 70.1125 million yuan, representing a growth of 4.48% [2]. - The securities lending balance decreased by 432.9 thousand yuan, indicating a decline of 6.65% [2].